Peptide Libraray

A4K14-citropin1.1-Sp7

General Information

DRACP ID DRACP05894

Peptide Name A4K14-citropin1.1-Sp7

Sequence GLFAVⓍKKVASVⓍKGL

Sequence Length 16

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

Cancer targeted peptides Stapled Peptides Membrane-targeted

Activity Information

Cell Line	Disease	Cancer Classified	Activity	Assay	Testing Time	Literature
C4-2B	Prostate carcinoma	Carcinoma	IC50=35.84 μM	CCK-8 assay	96 h	1
A549	Lung adenocarcinoma	Carcinoma	IC50=16.37 μM	CCK-8 assay	96 h	1
U87	Glioblastoma	Blastoma	IC50=14.72 μM	CCK-8 assay	96 h	1
MCF-7	Invasive breast carcinoma of no special type	Carcinoma	IC50=12.1 μM	CCK-8 assay	96 h	1

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Nature Anticancer

Structure Information

PDB ID Not available

Predicted Structure Not available

Helicity 13.6

Linear/Cyclic Cyclic (Stapled)

Disulfide/Other Bond Stapled: Ⓧ(6) and Ⓧ (13) are cross-linked by hydrocarbon stapling

N-terminal Modification Acetylation

C-terminal Modification Amidation

Other Modification Ⓧ(6)=(S)-2-(4-pentenyl)alanine; Ⓧ(13)=(R)-2-(7-octenyl)alanine

Chiral L

Physicochemical Information

Formula C67H113N17O14

Absent amino acids CDEHIMNPQRTWY

Common amino acids KV

Mass 164848

Pl 11.1

Basic residues 3

Acidic residues 0

Hydrophobic residues 8

Net charge 3

Boman Index 1039

Hydrophobicity 83.13

Aliphatic Index 115.63

Half Life
/

Extinction Coefficient cystines 0

Absorbance 280nm 0

Polar residues 3

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 33363118

Title Design, Synthesis, and Antitumor Activities Study of Stapled A4K14-Citropin 1.1 Peptides

Doi 10.3389/fchem.2020.616147

Year 2020

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available